These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33831263)

  • 21. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.
    Bonaventura A; Vecchié A; Dagna L; Martinod K; Dixon DL; Van Tassell BW; Dentali F; Montecucco F; Massberg S; Levi M; Abbate A
    Nat Rev Immunol; 2021 May; 21(5):319-329. PubMed ID: 33824483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopathogenesis and immunobiology of SARS-CoV-2.
    Rabaan AA; Al-Ahmed SH; Al Mutair A; Alhumaid S; Sule AA; Tirupathi R; Fawzy M; Muhammad J; Khan A; Hasan A; Shrestha DB; Sah R; Dhawan M; Tiwari R; Bilal M; Ahmad T; Dhama K
    Infez Med; 2021 Jun; 29(2):167-180. PubMed ID: 34061781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface.
    Leon J; Michelson DA; Olejnik J; Chowdhary K; Oh HS; Hume AJ; Galván-Peña S; Zhu Y; Chen F; Vijaykumar B; Yang L; Crestani E; Yonker LM; Knipe DM; Mühlberger E; Benoist C
    Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34969849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
    Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL
    J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T Cell Memory: Understanding COVID-19.
    Jarjour NN; Masopust D; Jameson SC
    Immunity; 2021 Jan; 54(1):14-18. PubMed ID: 33406391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients.
    Martín-Sánchez E; Garcés JJ; Maia C; Inogés S; López-Díaz de Cerio A; Carmona-Torre F; Marin-Oto M; Alegre F; Molano E; Fernandez-Alonso M; Perez C; Botta C; Zabaleta A; Alcaide AB; Landecho MF; Rua M; Pérez-Warnisher T; Blanco L; Sarvide S; Vilas-Zornoza A; Alignani D; Moreno C; Pineda I; Sogbe M; Argemi J; Paiva B; Yuste JR
    Front Immunol; 2021; 12():659018. PubMed ID: 34012444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune profiling of COVID-19: preliminary findings and implications for the pandemic.
    Maecker HT
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 infection: the perspectives on immune responses.
    Shi Y; Wang Y; Shao C; Huang J; Gan J; Huang X; Bucci E; Piacentini M; Ippolito G; Melino G
    Cell Death Differ; 2020 May; 27(5):1451-1454. PubMed ID: 32205856
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunopathology of Hyperinflammation in COVID-19.
    Gustine JN; Jones D
    Am J Pathol; 2021 Jan; 191(1):4-17. PubMed ID: 32919977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
    Ahmed F; Jo DH; Lee SH
    Front Immunol; 2020; 11():586765. PubMed ID: 33365027
    [No Abstract]   [Full Text] [Related]  

  • 35. Age-Related Differences in Immunological Responses to SARS-CoV-2.
    Wong LSY; Loo EXL; Kang AYH; Lau HX; Tambyah PA; Tham EH
    J Allergy Clin Immunol Pract; 2020; 8(10):3251-3258. PubMed ID: 32861856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19.
    Müller L; Di Benedetto S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak.
    Griffin DO; Jensen A; Khan M; Chin J; Chin K; Saad J; Parnell R; Awwad C; Patel D
    J Glob Antimicrob Resist; 2021 Mar; 24():90-92. PubMed ID: 33242672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VISTA: A Target to Manage the Innate Cytokine Storm.
    ElTanbouly MA; Zhao Y; Schaafsma E; Burns CM; Mabaera R; Cheng C; Noelle RJ
    Front Immunol; 2020; 11():595950. PubMed ID: 33643285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Covid-19 vaccines: delivering protective immunity.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Dec; 371():m4838. PubMed ID: 33334862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.